We have testing kits for Covid-19 In inventory now for immediate shipping. High sensitivity rapid test kits for Covid-19. 250K available now for USA and international shipping, Inventory moving fast.
Specification
Product Name VivaDiag SARS-CoV-2 IgM/IgG Rapid Test (COVID-19 IgM/IgG Rapid Test)
Test Principle Colloidal gold
Sample Type Whole blood (fingertip/venous ), serum or plasma
Sample Volume 10 �¼L
Test Time 15 min
Operation Temperature 15-30
Storage Temperature 2-30
Shelf Life (Unopened) 24 months
Covi-G (powered by Cipla) Rapid Test kit combines quality, efficacy and convenience - offering precise results in 10-15 mins
Features & Benefits
Covid IgM-IgG Serologic Rapid Test for COVID-19 is used to qualitatively detect IgG and IgM antibodies against SARS-CoV-2 in whole blood in vitro
Precise and effective
- Tests for both IgM and IgG antibodies
- Sensitivity and specificity comparable to highest available offerings Sensitivity: IgG 92%, IgM 82%; Specificity IgG 97%, IgM 94%
- ->92% total accuracy: IgG 96,5% - IgM: 92,8%
- High reproducibility (consistent results across the same patient)
-
High quality, reliable & convenient
- Single-prick blood test
- 10-15 minutes per test
- Intuitive visual interpretation
- No specialized training or equipment needed
- Portable hence highly scalable
- Storage at room temperature (2-30 C)
- Conformance to CE (Europe) and ISO manufacturing
The Covi-G platform for Rapid Antibody tests has a set of unique and unparalleled offerings
SUSTAINABLE QUALITY
Validated Declaration of CE conformity
- Launched in Feb 2020, among the earliest technologies/ kits to declare CE-compliance, and continuing strong compared to competitors
- Under process for receiving USDA E authorization
Among only 3 integrated vendors of Rapid tests Developed and manufactured in Europe (Belgium)
- One of the very lew players manufacturing in Europe, with zero complaints also certified locations
ACCEPTABILITY ACROSS MARKETS
Demonstrated capabilities in local countries validation
- Independent local studies conducted in Belgium and France, validating the sensitivity and specificity of the product
Participated in published research
- Covl-G kit compared lavorably with 7 lgFL IgM rapid antibody tests and IgG ELISA in a comparative study published by Elsevier Science Direct, verifying sensitivity of the kit
PROVEN COMMERCIAL EXPERIENCE
Sold in 25+ countries already
- Including Europe, US, Canada, Africa and multiple developed and emerging markets
- Under participation in govt tenders
Robust manufacturing capability and capacity
- ISO-certified manufacturing site
- Ability to cater to high manufacturing volumes from Belgium, to ensure adequale QA and commercial viability
AFFORDABLE AND SCALABLE
Viable to scale up at Institutions and Retail level
- Economical cost per-unit established over many months of process improvement and local manufacturing
- Can cater to insured as well as out-of pocket populations
Continuous improvement through R&D
- Multiple rounds of performance testing complete, further testing in 5 reputed hospitals underway in Belgium, France, USA and Canada
- Other platforms including Rapid antigen testing also being developed
A world of excellence in in vitro diagnostics produces and market
immunochemistry (elisa/eia clia/lia), urine reagent test strips, fertility's, serology, infectious disease rt, clia waived tests, drug screening, blood banking, clinical chemistry reagents, research chemistries, coagulation, dr.g glucometer, genotype molecular diagnostics assays , immunofluorescence assays, microbiology , covid 19 antigen /antibody rapid tests/elisa assays and pcr test kits, veterinary test kits, biodefense test kits and technology transfer..
